Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · May 9, 2009
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on collecting and storing tissue and blood samples from patients who have suspected solid tumors, which are abnormal growths in the body that may be cancerous. The goal of this study is to gather these samples so they can be used in future research to better understand and treat cancer. If you or a loved one is between the ages of 18 and 80 and is scheduled for surgery or a biopsy because of a suspected solid tumor, you might be eligible to participate in this trial.
Participants in the trial can expect to have samples collected during their surgical procedure. This process is an important step in helping researchers learn more about cancer and develop new treatments. The study is currently looking for volunteers, and anyone who meets the eligibility criteria can take part, regardless of gender. If you have any questions or are interested in participating, it's a good idea to talk to your doctor for more information.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinically suspected solid tumor AND scheduled for surgical resection and/or biopsy
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winston Salem, North Carolina, United States
Patients applied
Trial Officials
Edward A. Levine, MD
Study Chair
Wake Forest University Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials